There were 189 press releases posted in the last 24 hours and 437,648 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Ultragenyx Announces Orphan Drug Designation for UX701 for the Treatment of Wilson Disease

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image